Qisda Corp
TWSE:2352
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Qisda Corp
Cash Equivalents
Qisda Corp
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Qisda Corp
TWSE:2352
|
Cash Equivalents
NT$3.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
|
Quanta Computer Inc
TWSE:2382
|
Cash Equivalents
NT$88.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Asustek Computer Inc
TWSE:2357
|
Cash Equivalents
NT$34.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-3%
|
|
|
Asia Vital Components Co Ltd
TWSE:3017
|
Cash Equivalents
NT$12.3B
|
CAGR 3-Years
128%
|
CAGR 5-Years
149%
|
CAGR 10-Years
38%
|
|
|
Wistron Corp
TWSE:3231
|
Cash Equivalents
NT$31.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
1%
|
|
|
Wiwynn Corp
TWSE:6669
|
Cash Equivalents
NT$13.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Qisda Corp
Glance View
Qisda Corp., originally emerging from BenQ Corporation, has steadily charted its course within the competitive landscape of global technology solutions. Founded in Taiwan, Qisda began as a hardware manufacturer and burgeoned into a multifaceted company with interests spanning from IT products to healthcare solutions. The company’s DNA showcases its relentless pursuit of innovation alongside its commitment to delivering high-value products. By leveraging its extensive R&D capabilities, Qisda strives to integrate cutting-edge designs in its product offerings, ranging from monitors and projectors to sophisticated IoT solutions and medical devices. As the technology sphere evolves, Qisda has adeptly diversified its business portfolio, a strategy which secures its role as a key player in various technology-driven industries. The crux of Qisda's business model revolves around manufacturing and design services, underpinning its prominence in the OEM and ODM sectors. The company generates revenue by offering its high-tech design and manufacturing expertise to numerous global brands, creating a foundation of trust and quality through its expansive production facilities and a diversified client base. Moreover, Qisda’s engagement in the medical sector, via its subsidiary BenQ Medical Technology, is not just a remarkable expansion but a strategic pivot towards a nascent and profitable frontier. By aligning its technological prowess with healthcare innovation, Qisda is not only fortifying its revenue streams but also enhancing its resilience against market fluctuations, ensuring long-term growth and sustainability.
See Also
What is Qisda Corp's Cash Equivalents?
Cash Equivalents
3.1B
TWD
Based on the financial report for Dec 31, 2025, Qisda Corp's Cash Equivalents amounts to 3.1B TWD.
What is Qisda Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-4%
Over the last year, the Cash Equivalents growth was -54%. The average annual Cash Equivalents growth rates for Qisda Corp have been -26% over the past three years , -16% over the past five years , and -4% over the past ten years .